Bill Detail
S. 1717
Congress: 119
Title
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Sen. Todd Young [R-IN]
Status
Read twice and referred to the Committee on Finance.
Status as of Jun 29, 12:32 PM · synced 8h ago
Introduced
2025-05-12
Data source mode: cache
Bill Engagement
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Sponsor
Sen. Todd Young [R-IN]R
Status
Read twice and referred to the Committee on Finance.
Cosponsors
3D · 2R
Bipartisan
LDA engagement
8 orgs · 8 filings
Top: American Medical Association
Introduced
2025-05-12
Lobbyists on the case
8 orgs · 65 lobbyists · 8 filings mention S. 1717 (Ensuring Patient Access to Critical Breakthrough Products Act of 2025) in LDA disclosures.
Top orgs filing
- American Medical Association1 filing · 23 lobs
- Johnson & Johnson Services, Inc.1 filing · 16 lobs
- Alzheimer's Association1 filing · 8 lobs
- Advanced Medical Technology Assn1 filing · 6 lobs
- Emergent Strategies1 filing · 4 lobs
- Avenue Solutions1 filing · 3 lobs
Lobbyists on this bill
- Jane Adams2026 Q1
- Todd Askew2025 Q3
- Brett Baker2026 Q1The Nickles Group, LLC · U.S. Senate Committee on Finance (Senators Crapo, Grassley, and Hatch)-Deputy Health Policy Direc…
- Elizabeth Barnett2026 Q1
- Jamal Bowleg2025 Q3
- Leif Brierley2026 Q1
- Lindsey Brill2025 Q3
- Larry Camm2026 Q1
+ 57 more